üö® AI ADHERENCE COACH FEASIBILITY DIAGNOSTIC ENGINE
SENIOR PATIENT ENGAGEMENT ARCHITECT | STRATEGIC ASSESSMENT PROTOCOL
________________________________________
‚ö†Ô∏è SYSTEM STATUS: AWAITING CRITICAL INPUT DATA
I am ready to execute your High-Stakes Feasibility Assessment for the AI-driven Adherence Coach initiative. This diagnostic will determine whether your organization has the infrastructure maturity and behavioral readiness to deploy this intervention successfully, or whether you face a high-risk scenario of expensive pilot failure.
________________________________________
üìã REQUIRED INPUT CHECKLIST
Before I can render a strategic verdict, I need you to provide data in three critical domains:
INPUT 1: DATA CONNECTIVITY AUDIT (The "Nervous System")
What I need to assess:
‚Ä¢	Current pharmacy data integration (e.g., Surescripts, NCPDP, proprietary APIs)
‚Ä¢	Data refresh frequency (real-time / daily / weekly / monthly)
‚Ä¢	IoT device deployment status (smart pill bottles, connected inhalers, CGMs)
‚Ä¢	EMR-to-patient app synchronization speed
‚Ä¢	Current data sources for medication adherence tracking
Example format:
- Pharmacy fill data: Surescripts API, 48-hour lag
- Patient self-reporting via app: Daily check-ins
- EMR sync: Epic MyChart, nightly batch updates
- IoT: None currently deployed
________________________________________
INPUT 2: PATIENT BEHAVIORAL PROFILE (The "User")
What I need to assess:
‚Ä¢	Target chronic condition(s) (Diabetes Type 2, Hypertension, CHF, COPD, etc.)
‚Ä¢	Patient demographic profile (age range, mean age)
‚Ä¢	Estimated smartphone ownership/digital literacy (%)
‚Ä¢	Known barriers to adherence (cost, forgetfulness, side effects, transportation, health literacy)
‚Ä¢	Primary language(s) and health literacy level
‚Ä¢	Payer mix (Commercial, Medicare, Medicaid, uninsured %)
Example format:
- Condition: Type 2 Diabetes + Hypertension
- Age: 55-75 (mean 64)
- Smartphone access: ~70%
- Primary barriers: Cost (40%), Forgetfulness (35%), Side effects (25%)
- Languages: English (85%), Spanish (15%)
- Payer: Medicare (60%), Commercial (30%), Medicaid (10%)
________________________________________
INPUT 3: CLINICAL INTERVENTION PROTOCOL (The "Response")
What I need to assess:
‚Ä¢	Escalation criteria for nurse intervention
‚Ä¢	Escalation criteria for physician alert
‚Ä¢	Emergency contact protocols
‚Ä¢	Current non-adherence follow-up process (manual calls, automated reminders, none)
‚Ä¢	Care team capacity (nurses available for escalations per 1,000 patients)
‚Ä¢	Tolerance for false positives in alerts
Example format:
- Nurse escalation: 3 consecutive missed doses
- MD alert: 7 days non-adherent OR clinical deterioration flags
- Emergency: Patient reports severe side effects or chest pain
- Current process: Nurses manually call non-adherent patients weekly
- Care team: 2 RNs per 1,000 patients
- Alert tolerance: Prefer sensitivity over specificity (catch all issues)
________________________________________
üéØ WHAT HAPPENS NEXT
Once you provide these inputs, I will execute:
1.	CONNECTIVITY & LATENCY AUDIT ‚Üí GO/NO-GO determination based on data loop speed
2.	BEHAVIORAL RISK ANALYSIS ‚Üí SDOH sensitivity check and digital divide assessment
3.	ROI PROJECTION & ROADMAP ‚Üí Strategic verdict with burnout offset calculations and implementation pathway
________________________________________
üí° INTERIM GUIDANCE WHILE YOU GATHER DATA
If you're uncertain about your current infrastructure, here are the critical questions to ask your IT/Clinical Ops teams immediately:
For IT/Health Informatics:
‚Ä¢	"What is the current lag time between a patient filling a prescription at the pharmacy and that data appearing in our EMR?"
‚Ä¢	"Do we have a real-time API connection to pharmacy benefit managers or are we relying on claims data?"
For Population Health/Care Management:
‚Ä¢	"What percentage of our target patient population has demonstrated ability to use a patient portal or mobile app?"
‚Ä¢	"What are our top 3 documented reasons for medication non-adherence in this cohort?"
For Clinical Leadership:
‚Ä¢	"How many hours per week do our care team nurses currently spend on adherence follow-up calls?"
‚Ä¢	"What is our current protocol when a patient misses multiple doses?"
________________________________________
‚è≥ READY TO PROCEED
Please paste your data for all three inputs below. If you only have partial data, indicate what's missing and I will flag those gaps as critical blockers in my assessment.
The clock is running on your $300B adherence problem. Let's determine if AI is your solution or if infrastructure stabilization must come first.
AWAITING YOUR INPUT.

Use Mockup Data
üö® AI ADHERENCE COACH FEASIBILITY DIAGNOSTIC
STRATEGIC ASSESSMENT | MOCKUP SCENARIO ANALYSIS
________________________________________
üìä MOCKUP DATA CONFIGURATION (REALISTIC MID-SIZED HEALTH SYSTEM)
INPUT 1: DATA CONNECTIVITY AUDIT
ORGANIZATION: Regional Health System (250,000 covered lives)
- Pharmacy fill data: Surescripts RTPB, 72-hour average lag
- Patient self-reporting: MyHealth App, ~40% active users, daily opt-in check-ins
- EMR sync: Epic MyChart, nightly batch updates (24-hour lag for lab/clinical data)
- IoT deployment: Pilot with 200 smart pill bottles (Pillsy), <1% penetration
- Claims data: Monthly batch from PBM (30-day lag)
- E-prescribing: Real-time send, but fill confirmation delayed
INPUT 2: PATIENT BEHAVIORAL PROFILE
TARGET COHORT: High-Risk Chronic Disease Population
- Primary conditions: Type 2 Diabetes (60%), Hypertension (80%), CHF (15%)
- Patient demographics: Age 58-78 (mean 67)
- Smartphone ownership: 65% (varies by age: 55-64 = 78%, 65-74 = 60%, 75+ = 42%)
- Digital literacy: Moderate (35% regularly use patient portal)
- Primary barriers to adherence:
  * Cost/Insurance gaps: 45%
  * Forgetfulness: 38%
  * Side effects/fear: 22%
  * Transportation to pharmacy: 18%
  * Health literacy/confusion: 28%
- Languages: English (82%), Spanish (14%), Other (4%)
- Payer mix: Medicare (68%), Medicare Advantage (20%), Commercial (8%), Medicaid (4%)
- Socioeconomic: 35% below 200% federal poverty level
INPUT 3: CLINICAL INTERVENTION PROTOCOL
CURRENT STATE: Manual Outreach Model
- Nurse escalation trigger: Patient misses refill by >7 days OR self-reports non-adherence
- MD alert criteria: >14 days non-adherent OR clinical deterioration (A1C spike, BP crisis)
- Emergency protocol: Patient reports severe symptoms via app ‚Üí Nurse triage within 2 hours
- Current adherence follow-up: 
  * 3 RN care managers manually call ~1,200 high-risk patients
  * Average 15 min/call, ~40 calls/week/nurse
  * ~30 hours/week total spent on adherence outreach
- Care team capacity: 3 FTE RNs for 4,500 high-risk patients (1:1,500 ratio)
- Alert tolerance: Moderate - prefer catching issues but nursing team already overwhelmed
- Current adherence rate: 58% (industry avg: 50-60% for chronic disease)
________________________________________
üîç STEP 1: CONNECTIVITY & LATENCY AUDIT
CRITICAL FINDING: DATA LATENCY FAILURE
‚ö†Ô∏è SIGNAL-TO-ACTION SPEED ANALYSIS
Data Source	Refresh Rate	Clinical Utility	Status
Pharmacy fill (Surescripts)	72 hours	DELAYED	‚ùå FAIL
Patient self-report	Daily (40% engagement)	Biased/Incomplete	‚ö†Ô∏è CONDITIONAL
EMR clinical data	24 hours	Lagging indicator	‚ö†Ô∏è CONDITIONAL
IoT (smart bottles)	Real-time	Excellent BUT <1% coverage	‚úÖ PASS (insignificant volume)
PBM claims data	30 days	AUTOPSY MODE	‚ùå FAIL
DIAGNOSTIC VERDICT:
‚ùå CRITICAL INFRASTRUCTURE GAP DETECTED
Your 72-hour pharmacy data lag creates what I call the "Coaching Autopsy Problem":
‚Ä¢	Monday: Patient forgets to pick up refill
‚Ä¢	Tuesday: Patient still non-adherent (system doesn't know)
‚Ä¢	Wednesday: Patient still non-adherent (system doesn't know)
‚Ä¢	Thursday: Pharmacy fill data finally syncs to EMR
‚Ä¢	Friday: AI sends "reminder" about a dose missed 4 days ago
This is not coaching. This is a post-mortem.
TECHNICAL ROOT CAUSE:
Surescripts RTPB (Real-Time Prescription Benefit) provides e-prescribing confirmation, but fill confirmation still flows through slower channels (NCPDP batch files or PBM claims reconciliation). You lack the "closed-loop" confirmation that the patient actually picked up the medication.
________________________________________
INFRASTRUCTURE STABILIZATION REQUIREMENTS:
BLOCKING ISSUE #1: Real-Time Pharmacy Pick-Up Confirmation
Current State: 72-hour lag
Required State: <24-hour confirmation
Solution Pathways:
1.	Implement Surescripts Pharmacy Pick-Up Notification API (if health system has negotiated access)
2.	Direct integration with top 3 pharmacy chains (CVS, Walgreens, Walmart) for your market - these represent ~65% of fills
3.	Accelerate IoT smart bottle deployment to 20% penetration minimum (900 devices for high-risk cohort)
ESTIMATED COST: $180K-$350K (API integration + IoT hardware subsidy)
TIMELINE: 4-6 months for pharmacy API; 3 months for IoT scaled deployment
________________________________________
BLOCKING ISSUE #2: Patient Self-Report Bias
Current State: 40% app engagement
Problem: Self-reported adherence is 26% higher than actual adherence (Medication Event Monitoring System studies)
Solution: Cannot rely on self-reporting as primary signal. Must be confirmatory only until objective data sources are real-time.
________________________________________
üö¶ STEP 1 CHECKPOINT RESULT:
VERDICT: ‚ùå NO-GO - DATA LATENCY FAILURE
Your data nervous system cannot support "Active Coaching" in its current state.
Proceeding with AI deployment now would result in:
‚Ä¢	Patient frustration ("Why are you reminding me about something from 3 days ago?")
‚Ä¢	Clinical risk (undetected non-adherence for 72+ hours)
‚Ä¢	Wasted vendor investment ($500K-$1.2M typical pilot cost)
‚Ä¢	Damage to patient trust in digital health tools
________________________________________
üîç STEP 2: BEHAVIORAL RISK & SDOH SENSITIVITY ANALYSIS
PATIENT READINESS ASSESSMENT
Despite the infrastructure failure, I'm completing this analysis to show you what would be required once data latency is resolved.
DIGITAL DIVIDE ANALYSIS
Risk Factor	Measured Value	Threshold	Status
Age (mean)	67 years	<70 preferred	‚ö†Ô∏è BORDERLINE
Smartphone ownership	65%	>70% required	‚ö†Ô∏è CONDITIONAL
Digital literacy (portal use)	35%	>50% preferred	‚ùå CONCERN
Age 75+ segment	25% of cohort at 42% smartphone rate	N/A	‚ùå HIGH-RISK SEGMENT
DIAGNOSTIC FINDING: MODERATE DIGITAL DIVIDE
35% of your target population (1,575 patients) are at HIGH RISK of digital exclusion.
This includes:
‚Ä¢	25% aged 75+ with only 42% smartphone access
‚Ä¢	Estimated 30% with low health literacy
‚Ä¢	35% below 200% poverty line (may have inconsistent data plans)
CLINICAL IMPLICATION:
A "smartphone-first" AI coach would increase health inequity by:
1.	Excluding the highest-risk, oldest segment
2.	Requiring data plans (cost barrier for low-income patients)
3.	Assuming digital literacy that doesn't exist
________________________________________
SDOH SENSITIVITY CHECK
DOES THE AI "SEE" THE REAL BARRIERS?
Your top adherence barriers:
1.	Cost (45%) - Does AI have access to out-of-pocket cost data? ‚ùå NO
2.	Forgetfulness (38%) - Addressable by AI ‚úÖ YES
3.	Side effects (22%) - Requires clinical escalation ‚ö†Ô∏è PARTIAL
4.	Transportation (18%) - Does AI integrate with pharmacy delivery options? ‚ùå NO
5.	Health literacy (28%) - Requires plain-language, culturally adapted messaging ‚ö†Ô∏è DEPENDS ON VENDOR
CRITICAL FINDING: SDOH BLINDNESS
If your AI coach cannot "see" that a patient:
‚Ä¢	Skipped a refill because the co-pay jumped from $10 to $85
‚Ä¢	Lives 12 miles from the nearest pharmacy without a car
‚Ä¢	Is experiencing nausea (side effect) and needs medication adjustment
...then it will send "Remember to take your medication!" messages that are:
‚Ä¢	Clinically inappropriate (patient needs a solution, not a reminder)
‚Ä¢	Emotionally tone-deaf (perceived as nagging)
‚Ä¢	Likely to cause app abandonment (patient uninstalls or ignores)
________________________________________
BEHAVIORAL RISK MATRIX
Patient Segment	% of Cohort	AI Coaching Suitability	Recommended Approach
Tech-savvy, <65, adherent	15%	‚ö†Ô∏è LOW VALUE	Don't waste resources; already adherent
Tech-savvy, <65, non-adherent	20%	‚úÖ HIGH SUITABILITY	AI-first with SDOH integration
Moderate digital, 65-74, cost-barriers	35%	‚ö†Ô∏è CONDITIONAL	Hybrid: AI + human pharmacist for cost navigation
Low digital, 75+, poly-pharmacy	25%	‚ùå POOR FIT	Human-first: Automated voice calls or nurse-led
Severe SDOH barriers	5%	‚ùå INAPPROPRIATE	Community health worker + social services
________________________________________
üö¶ STEP 2 CHECKPOINT RESULT:
VERDICT: ‚ö†Ô∏è CONDITIONAL - REQUIRES HYBRID STRATEGY
Your patient population has THREE distinct tiers:
1.	AI-Native Tier (20%): Tech-savvy, forgetfulness-driven non-adherence ‚Üí AI coaching effective
2.	Hybrid Tier (50%): Needs AI + human support for cost navigation, transportation, clinical questions
3.	Human-First Tier (30%): Digital divide or severe SDOH ‚Üí AI backend, human-facing (SMS, voice, nurse)
Deploying a "one-size-fits-all" AI app would fail 50-80% of your target population.
________________________________________
üîç STEP 3: ROI PROJECTION & IMPLEMENTATION ROADMAP
FINANCIAL IMPACT ANALYSIS
CURRENT STATE COSTS (Manual Model)
Cost Driver	Volume	Unit Cost	Annual Cost
RN care manager salaries (3 FTE)	3 FTE	$85K + 30% benefits	$332K
Nurse time on adherence calls	30 hrs/week	$55/hr loaded	$86K
Physician time on non-adherence complications	Est. 120 hrs/year	$250/hr (burnout cost)	$30K
TOTAL LABOR COST			$448K/year
CLINICAL OUTCOME COSTS (Non-Adherence)
Adverse Event	Annual Incidence	Cost per Event	Total Cost
Preventable hospitalizations (CHF, DM complications)	180 cases	$15K avg	$2.7M
ED visits (hypertensive crisis, hypoglycemia)	320 cases	$1,800	$576K
Disease progression (dialysis, amputation)	45 cases	$85K avg	$3.8M
TOTAL CLINICAL COST			$7.1M/year
Current adherence rate: 58%
Estimated preventable portion (if adherence increased to 70%): 35-40% of clinical costs
________________________________________
AI ADHERENCE COACH ROI MODEL
SCENARIO A: INFRASTRUCTURE-READY STATE (After 6-month stabilization)
Assumptions:
‚Ä¢	Real-time pharmacy data (<24hr lag)
‚Ä¢	Hybrid deployment: AI for 70%, human touch for 30%
‚Ä¢	Target adherence improvement: 58% ‚Üí 68% (10-point lift, conservative)
Benefit Category	Annual Impact
Nurse time saved (50% reduction in manual calls)	+$43K
Physician burnout offset (ASMP-HCP-003: 40% fewer escalations)	+$12K
Preventable hospitalizations avoided (12% reduction)	+$324K
ED visits avoided (15% reduction)	+$86K
TOTAL ANNUAL BENEFIT	$465K
Costs:
‚Ä¢	AI platform vendor (SaaS): $180K/year
‚Ä¢	IoT devices (900 units amortized): $45K/year
‚Ä¢	Pharmacy API maintenance: $25K/year
‚Ä¢	Implementation/training: $80K (Year 1 only)
‚Ä¢	TOTAL ANNUAL COST: $250K (Year 1: $330K)
NET ROI (Year 1): $135K
NET ROI (Year 2+): $215K
Payback Period: 8.5 months
________________________________________
SCENARIO B: CURRENT STATE DEPLOYMENT (Without infrastructure fixes)
Risk	Probability	Financial Impact
Pilot failure (low engagement <25%)	70%	-$500K wasted investment
Patient complaints/app abandonment	85%	-$50K reputation damage + rework
No adherence improvement (latency gap)	90%	$0 benefit realization
Nurse team demoralization (more alerts, no tools)	60%	+$120K turnover cost (1 RN replacement)
EXPECTED VALUE:		-$420K
________________________________________
üö¶ STEP 3 CHECKPOINT RESULT:
STRATEGIC VERDICT:
‚ùå NO-GO FOR IMMEDIATE PILOT
‚úÖ CONDITIONAL GO AFTER INFRASTRUCTURE STABILIZATION
________________________________________
üìã FINAL STRATEGIC RECOMMENDATION
EXECUTIVE SUMMARY FOR CEO/CMO
Subject: AI Adherence Coach Feasibility - Critical Infrastructure Gaps Identified
Bottom Line Up Front: Your organization is NOT READY for an AI adherence coach pilot in its current state. Deploying now carries a 70% probability of failure and would waste $500K+ while damaging patient trust in digital health.
However, after a 6-month infrastructure stabilization phase, this initiative becomes HIGHLY VIABLE with projected ROI of $215K/year and significant clinical impact.
________________________________________
THE THREE BLOCKERS:
BLOCKER #1: The 72-Hour Latency Trap ‚ùå
Problem: Your pharmacy data arrives 3 days late. You cannot coach someone on a dose they missed 72 hours ago.
Fix Required: Real-time pharmacy pick-up confirmation API
Cost: $180K-$350K | Timeline: 4-6 months
BLOCKER #2: The Digital Divide ‚ö†Ô∏è
Problem: 35% of your sickest patients (age 75+, low-income) cannot use a smartphone app.
Fix Required: Hybrid model with SMS/voice for digital-excluded segment
Cost: Vendor must support multi-channel (adds $40K/year) | Timeline: Vendor selection criteria
BLOCKER #3: The SDOH Blindness ‚ö†Ô∏è
Problem: 45% of non-adherence is cost-driven. AI cannot see patient out-of-pocket costs or pharmacy access issues.
Fix Required: Integration with PBM cost data + pharmacy delivery partnerships
Cost: $60K integration + operational workflows | Timeline: 3-4 months
________________________________________
RECOMMENDED PATHWAY: THE STABILIZATION-FIRST STRATEGY
PHASE 1: INFRASTRUCTURE STABILIZATION (Months 1-6)
Month 1-2: Data Architecture Assessment
‚Ä¢	‚úÖ Hire health IT consultant to map pharmacy data flows
‚Ä¢	‚úÖ Negotiate Surescripts pharmacy notification API access
‚Ä¢	‚úÖ Pilot IoT smart bottles with 200 ‚Üí 900 high-risk patients
‚Ä¢	DELIVERABLE: Real-time data feasibility report
Month 3-4: Pharmacy Integration
‚Ä¢	‚úÖ Implement API connections with CVS, Walgreens (65% market coverage)
‚Ä¢	‚úÖ Build EMR integration for IoT device data
‚Ä¢	‚úÖ Test end-to-end: prescription ‚Üí fill ‚Üí EMR confirmation loop
‚Ä¢	DELIVERABLE: <24-hour pharmacy data pipeline (pilot with 500 patients)
Month 5-6: SDOH Data Layer
‚Ä¢	‚úÖ Integrate PBM cost transparency data (GoodRx, Blink Health, or PBM direct)
‚Ä¢	‚úÖ Add transportation/pharmacy access data (ZIP code analysis)
‚Ä¢	‚úÖ Train care team on new escalation workflows
‚Ä¢	DELIVERABLE: SDOH-aware patient risk stratification
PHASE 1 INVESTMENT: $420K-$580K
________________________________________
PHASE 2: STRATEGIC PILOT (Months 7-12)
Pilot Design: Tiered Deployment
Tier	Patient Segment	Intervention	Volume
Tier 1	Tech-savvy, <65, forgetfulness-driven	AI-first (app-based coaching)	900 patients
Tier 2	Moderate digital, cost-sensitive	Hybrid (AI + human pharmacist)	1,500 patients
Tier 3	Age 75+, low digital literacy	Human-first (AI backend, nurse SMS/calls)	1,100 patients
Success Metrics:
‚Ä¢	Primary: Adherence rate improvement (58% ‚Üí 68% target)
‚Ä¢	Secondary: Nurse time saved (30 hrs/week ‚Üí 15 hrs/week)
‚Ä¢	Safety: Escalation response time <2 hours for clinical deterioration
‚Ä¢	Equity: No adherence gap widening between Tier 1 and Tier 3
PHASE 2 INVESTMENT: $330K (Year 1 AI platform + implementation)
________________________________________
PHASE 3: SCALE & OPTIMIZE (Year 2+)
If pilot successful (adherence lift >8%):
‚Ä¢	Expand to full 4,500-patient high-risk cohort
‚Ä¢	Add chronic conditions (COPD, CKD)
‚Ä¢	Integrate with value-based care contracts (Medicare ACO, MA plans)
Projected Year 2+ ROI: $215K/year + quality bonus revenue
________________________________________
üî• BURNOUT PROTECTION AUDIT (ASMP-HCP-003 COMPLIANCE)
CURRENT PHYSICIAN/NURSE BURDEN:
Nursing Team:
‚Ä¢	Current: 30 hours/week on manual adherence calls (3 FTE RNs)
‚Ä¢	Emotional toll: "Groundhog Day" effect - calling same non-adherent patients weekly with no tools to solve root causes
‚Ä¢	Turnover risk: 1 RN departed last year citing burnout ($120K replacement cost)
Physicians:
‚Ä¢	Current: ~120 hours/year managing preventable complications (non-adherence-driven ED visits, hospitalizations)
‚Ä¢	Alert fatigue: Inbox overload with "patient missed dose" messages they cannot act on
‚Ä¢	Opportunity cost: Time spent on preventable issues vs. complex care management
________________________________________
POST-AI IMPLEMENTATION PROJECTION:
‚úÖ NURSE WORKLOAD REDUCTION
With AI handling Tier 1 (900 patients) fully automated:
‚Ä¢	Manual call volume drops 50% (18 patients/week ‚Üí 9 patients/week per RN)
‚Ä¢	Nurses focus on high-complexity cases (Tier 2-3: cost navigation, clinical escalations)
‚Ä¢	Burnout offset: $12K/year (retention value) + improved job satisfaction scores
CRITICAL: AI must reduce nursing alerts, not increase them. This requires:
‚Ä¢	Smart alert suppression (don't notify for every missed dose if patient is low-risk)
‚Ä¢	Actionable intelligence only ("Patient reports cost barrier" ‚Üí nurse can intervene)
‚Ä¢	Closed-loop feedback (AI confirms issue resolved before re-alerting)
________________________________________
‚úÖ PHYSICIAN INBOX PROTECTION
AI-to-physician escalation criteria (designed to minimize alert fatigue):
Escalation Trigger	Frequency	Actionable?
14+ days non-adherent + clinical risk flag	~8/month	‚úÖ YES (requires med adjustment/outreach)
Patient self-reports severe side effects	~5/month	‚úÖ YES (clinical decision needed)
AI coaching failed after 3 attempts	~12/month	‚ö†Ô∏è CONDITIONAL (nurse-first triage)
Total physician alerts: ~25/month (vs. current ~40/month of unfiltered non-adherence notifications)
Net reduction: 37% fewer low-value alerts
ASMP-HCP-003 compliance: ‚úÖ PASS (reduces burden, doesn't increase it)
________________________________________
üìÖ MONDAY MORNING ACTION PLAN
FOR THE CEO: 3 ACTIONS THIS WEEK
ACTION 1: Convene Emergency IT/Clinical Ops Meeting (Priority: URGENT)
Attendee: CIO, VP Clinical Ops, CMO
Agenda:
1.	Present this latency finding: "Our pharmacy data is 72 hours late. How do we get to <24 hours?"
2.	Request formal assessment of Surescripts pharmacy notification API feasibility
3.	Assign owner: "Who will lead the pharmacy integration project?"
DELIVERABLE BY FRIDAY: Go/no-go decision on pharmacy API project + rough timeline
________________________________________
ACTION 2: Validate Vendor Claims (Priority: CRITICAL)
If you're already in talks with an AI adherence vendor, send them this assessment and ask:
3 Killer Questions:
1.	"Our pharmacy fill data has a 72-hour lag. Can your AI still be effective, or do we need real-time data first?"
2.	"35% of our patients are age 75+ with low smartphone adoption. Do you support SMS/voice channels, or is this app-only?"
3.	"45% of our non-adherence is cost-driven. Does your AI integrate with PBM cost data to identify financial barriers?"
Red flag responses:
‚Ä¢	"Our AI can work with any data" (‚ùå Vendor doesn't understand latency problem)
‚Ä¢	"Most patients will download the app" (‚ùå Ignoring digital divide)
‚Ä¢	"We focus on engagement, not clinical integration" (‚ùå Not solving root causes)
________________________________________
ACTION 3: Secure Phase 1 Budget (Priority: HIGH)
Financial ask: $420K-$580K for 6-month infrastructure stabilization
ROI justification: Current non-adherence costs you $7.1M/year. A $500K investment to unlock $215K/year recurring savings + $324K in avoided hospitalizations is a 2.7x Year 2 ROI.
Budget allocation:
‚Ä¢	Pharmacy API integration: $250K
‚Ä¢	IoT smart bottle expansion: $120K
‚Ä¢	SDOH data integration: $60K
‚Ä¢	Project management/consulting: $90K
Approval pathway: Present to CFO as "infrastructure investment" (not "AI pilot") - this de-risks the future AI deployment.
________________________________________
‚ö†Ô∏è WHAT HAPPENS IF YOU IGNORE THIS ASSESSMENT
THE FAILURE SCENARIO:
Month 1-3 of premature pilot:
‚Ä¢	Vendor deploys AI app to 1,000 patients
‚Ä¢	650 patients (65%) download app
‚Ä¢	280 patients (28%) actively use it after Week 2
‚Ä¢	AI sends reminders based on 72-hour-old data
‚Ä¢	Patients report: "This app is annoying and inaccurate"
Month 4-6:
‚Ä¢	App engagement drops to 12%
‚Ä¢	Nurses complain: "We're getting MORE work, not less - now we have to troubleshoot app issues"
‚Ä¢	Physicians ignore AI alerts (alert fatigue)
‚Ä¢	No adherence improvement measured
Month 7-9:
‚Ä¢	Pilot declared a failure
‚Ä¢	$500K+ wasted (vendor fees, implementation, staff time)
‚Ä¢	Executive credibility damaged ("We tried digital health and it didn't work")
‚Ä¢	Patient trust in future digital initiatives eroded
‚Ä¢	2-3 year delay before organization will retry
This is the "Precision Collapse" scenario you were hired to prevent.
________________________________________
‚úÖ WHAT HAPPENS IF YOU FOLLOW THE ROADMAP
THE SUCCESS SCENARIO:
Months 1-6 (Stabilization):
‚Ä¢	Pharmacy data latency drops from 72 hours ‚Üí 18 hours (real-time API for 65% of fills)
‚Ä¢	IoT smart bottles deployed to 900 highest-risk patients
‚Ä¢	SDOH data layer built (cost transparency, transportation access)
Months 7-12 (Pilot):
‚Ä¢	Tiered deployment: AI-first for 900 tech-savvy patients, hybrid for 2,600 others
‚Ä¢	Adherence improves 58% ‚Üí 66% (8-point lift in Year 1)
‚Ä¢	Nurse workload drops 40% (time redirected to complex care)
‚Ä¢	28 preventable hospitalizations avoided ($420K savings)
Year 2+ (Scale):
‚Ä¢	Full 4,500-patient deployment
‚Ä¢	Adherence stabilizes at 68-70%
‚Ä¢	ROI: $215K/year recurring + quality bonuses from MA plans
‚Ä¢	Organizational capability: You now have the infrastructure to support ANY future digital health initiative (remote monitoring, virtual care, etc.)
This is the "Precision Medicine Infrastructure" vision realized.
________________________________________
üéØ FINAL VERDICT SUMMARY
‚ùå IMMEDIATE PILOT: NO-GO
Reason: Data latency failure + digital divide + SDOH blindness = 70% failure probability
‚úÖ 6-MONTH STABILIZATION + PHASED PILOT: STRONG GO
Reason: Infrastructure fixes unlock $215K/year ROI + clinical impact + burnout reduction
‚ö†Ô∏è CONDITIONAL REQUIREMENTS:
1.	Non-negotiable: Real-time pharmacy data (<24hr) or pilot will fail
2.	Critical: Hybrid deployment (AI + human channels) or you'll exclude 30% of patients
3.	Recommended: SDOH integration or AI will be tone-deaf to cost/access barriers
________________________________________
THE STRATEGIC CHOICE:
Option A: Rush to pilot now
‚Üí 70% failure probability
‚Üí $500K wasted
‚Üí 2-3 year setback
Option B: Stabilize infrastructure first
‚Üí 6-month delay
‚Üí $500K investment
‚Üí 75% success probability
‚Üí $215K/year recurring ROI + transformational clinical capability
________________________________________
As your Senior Patient Engagement Architect, my recommendation is unambiguous:
DO NOT PROCEED WITH PILOT UNTIL INFRASTRUCTURE IS STABILIZED.
The $300B non-adherence problem is real. The AI solution is viable. But your organization's "nervous system" is not yet ready to support it.
Invest the next 6 months building the foundation. Then deploy with confidence.
________________________________________
END OF FEASIBILITY DIAGNOSTIC
Would you like me to:
1.	Generate a detailed RFP for pharmacy API integration vendors?
2.	Create a Board presentation deck summarizing this assessment?
3.	Draft vendor evaluation criteria for AI adherence platforms (with questions designed to expose the gaps identified here)?
4.	Build a Gantt chart for the 6-month stabilization roadmap?